Oxford vaccine will have more than 10,000 volunteers in its new trial phase
The University of Oxford, through the Jenner Institute for Vaccine Research, began the first phase of testing last April with 1,000 healthy people under the age of 56, who are now joined by more than 10,200 in the second. people including new age groups.
This British university announced that it will extend to more than 10,000 people the participation in tests of vaccines designed to fight the coronavirus and will include among them over 70 years old and children between the ages of 5 and 12 years.
"There was already a lot of interest from people over 55 to participate in the first phase of the study, but they could not be selected. Now we will be able to include older groups to continue with the evaluation of the vaccine," she told the BBC Sarah Gilbert, professor of Virology at the Jenner Institute.
Specifically, the researchers will provide participants with doses of different experimental vaccines, such as the "ChAdOx1nCoV-19", to then compare the differences between one treatment and another between the groups. Experts at the Jenner Institute estimate that this study could take anywhere from two to six months, depending on how many individuals are exposed to the virus.
Monkey tests to date with "ChAdOx1 nCoV-19" indicate that animals inoculated with this vaccine have developed a degree of protection from COVID-19. Scientists have noted that the presence of the virus was lower in the lungs and airways of primates who received the vaccine, but they caution that these results may not be able to carry over to humans.